Current management of @entity8 ( @entity359 ) include observation, transcatheter embolization and partial or total nephrectomy. @entity1 symptoms and size of the lesion are the determinants for the choice of the treatment. In general symptomatic or greater than 8 cm masses require intervention. A retrospective study of five @entity1 presented with symptomatic lesions and treated with selective transcatheter embolization, over a 3 year period was performed in our hospital. A total of eight embolizations were performed, all on an emergency basis due to @entity548 or significant @entity811 . Surgical intervention was necessary in one case, due to massive rebleeding on the fourth post-procedural day. Two @entity1 rebled within 6 months and 2 years respectively, and were managed successfully with additional embolization. The remaining two @entity1 are still asymptomatic 26 and 18 months after the successful initial result. Experience with this procedure is reported on with emphasis to the clinical outcome. It is believed that selective @entity1416 should be the standard initial therapy for symptomatic renal @entity359 .

Selective @entity1416 in the management of symptomatic XXXX .

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients'] @entity8 :: ('MESH:D007674', 'Disease') :: ['renal angiomyolipomas'] @entity548 :: ('MESH:D006470', 'Disease') :: ['retroperitoneal bleeding'] @entity1416 :: ('MESH:D020762', 'Disease') :: ['arterial embolization'] @entity359 :: ('MESH:D018207', 'Disease') :: ['AMLs'] @entity811 :: ('MESH:D006417', 'Disease') :: ['hematuria']
@entity8 :: (MESH:D007674,Disease) :: ['renal angiomyolipomas']
